Clinical trial

Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy

NCT00361023

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-01-01

PhaseNA

Study timeline

Study start (unknown)2006-01-01Date precision: month

Registry last updated2006-08-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Diabetic Nephropathyunresolved

Interventions

losartanDRUG · verified · RxNorm: losartan

Sponsors & collaborators

Shanghai Jiao Tong University School of Medicinelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00361023 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.